Regarding the effectiveness of venetoclax in AML NPM1mut, the human monocytic leukemia cell line THP-1, when transfected with a NPM1mut containing vector, exhibits increased sensitivity to chemotherapies through the reduction in NF-κB activity and BCL-2/BAX expression [95]. The gene discussed is BCL2; the disease is acute myeloid leukemia.